ISIS Pharmaceuticals (ISIS): Q3 EPS of -$0.37 misses by $0.26. Revenue of $11.6M misses by $28M....

|By:, SA News Editor
ISIS Pharmaceuticals (ISIS): Q3 EPS of -$0.37 misses by $0.26. Revenue of $11.6M misses by $28M. (PR)